Physician

Michael Warren Pelster, M.D.

According to 2025 Medicare claims, Michael Pelster, M.D. (NPI: 1699017145) practices micrographic dermatologic surgery in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. This provider's primary affiliated billing organization is NASHVILLE SKIN AND CANCER, PLC (NPI: 1497700231; TIN: 202493384) and primary practice location at 37212-4908.

Pelster's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 813 traditional Medicare patients, billed 3,520 HCPCS/CPT codes, and received $331,171 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 840 prescription claims across 372 beneficiaries totaling $297,164 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 89 records totaling $1,640. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $519 to $297,164. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	185	581	$161,878
2019	394	1,303	$368,118
2020	330	971	$288,924
2021	473	1,564	$311,685
2022	577	2,363	$332,697
2023	718	3,328	$334,026
2024	813	3,520	$331,171

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	15	19	$519
2018	171	282	$5,037
2019	419	699	$10,438
2020	166	275	$3,592
2021	190	304	$6,617
2022	239	443	$82,600
2023	340	735	$239,254
2024	372	840	$297,164

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	164	202	$429
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	366	479	$56
11102	Biopsy of related skin growth, first growth	254	310	$53
17000	Destruction of precancer skin growth, 1 growth	328	425	$31
17003	Destruction of precancer skin growth, 2-14 growths	199	711	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	13	336	$47,683
Clobetasol Propionate	Clobetasol Propionate	100	2,930	$3,835
Tacrolimus	Tacrolimus	14	596	$2,364
Doxycycline Hyclate	Doxycycline Hyclate	167	3,830	$2,316
Ketoconazole	Ketoconazole	115	3,433	$2,066

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	89	$1,640	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Warren Pelster, M.D.?

Tedicare shows public-source Medicare data for Michael Warren Pelster, M.D. (NPI 1699017145), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Warren Pelster, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Warren Pelster, M.D.?

Michael Warren Pelster, M.D. is linked to NASHVILLE SKIN AND CANCER, PLC (billing NPI 1497700231) in the available physician profile data.

Does Michael Warren Pelster, M.D. have Open Payments data?

Michael Warren Pelster, M.D. has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.